It's a programme headed by obesity experts who have spent more than 20 years helping people achieve sustained weight loss
The post lists persistent gastrointestinal side effects, pursuing pregnancy, requiring surgery, and wanting to assess true baseline appetite after extended treatment as scenarios where a temporary pause may come up
The PlexusDx Precision Peptide Genetic Test ($298) analyzes variants in GIPR and FTO, and MC4R genes across 14 metabolic pathways, which can reveal how your body responds to semaglutide and may influence pain perception and GI tolerance
Dou Y, Lee A, Zhu L, Morton J, Ladiges W
[1] Retatrutide: What the Evidence Actually Shows Retatrutides pivotal obesity dataset is a Phase 2, double-blind, randomised, placebo-controlled trial in adults with obesity (or overweight plus a weight-related condition), testing once-weekly doses up to 12 mg over 48 weeks